Cidara Therapeutics, Inc. (CDTX)

Cidara Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	127.39	35.78	32.73	59.68	35.91	50.27
Cash & Short-Term Investments	127.39	35.78	32.73	59.68	35.91	50.27
Cash Growth	161.73%	9.31%	-45.16%	66.18%	-28.56%	-32.58%
Accounts Receivable	1.7	16.25	5.83	5.36	11.18	0.01
Receivables	1.7	16.25	5.83	5.36	11.18	0.01
Inventory	-	6.1	-	-	-	-
Prepaid Expenses	27.69	2.73	6.53	4.07	3.07	5.54
Restricted Cash	-	-	-	2.59	7.04	10
Total Current Assets	156.77	60.86	45.09	71.7	57.19	65.81
Property, Plant & Equipment	4.32	5.13	1.32	2.54	1.21	2.06
Other Long-Term Assets	1.24	1.05	1.07	1.08	2.02	1.1
Total Assets	162.33	67.03	47.49	75.33	60.42	68.98
Accounts Payable	2.97	3.77	1.45	1.3	4.57	1.89
Accrued Expenses	39.79	37.25	24.13	15.06	12.17	7.73
Current Portion of Long-Term Debt	-	-	-	2.59	7.02	9.97
Current Portion of Leases	1.58	1.3	1.21	1.15	0.94	0.82
Current Unearned Revenue	-	25.1	14.61	13.92	13.87	9.8
Total Current Liabilities	44.34	67.42	41.4	34.02	38.56	30.2
Long-Term Leases	2.36	3.58	-	1.32	-	0.94
Long-Term Unearned Revenue	-	4.25	20.53	18.41	11.15	-
Total Liabilities	46.7	75.24	61.93	53.75	49.71	31.14
Common Stock	0	0.01	0.01	0.01	0	0
Additional Paid-In Capital	674.58	433.21	404.06	398.73	345.41	297.66
Retained Earnings	-558.95	-441.43	-418.5	-377.17	-334.7	-259.83
Total Common Equity	115.63	-8.21	-14.44	21.57	10.72	37.84
Shareholders' Equity	115.63	-8.21	-14.44	21.57	10.72	37.84
Total Liabilities & Equity	162.33	67.03	47.49	75.33	60.42	68.98
Total Debt	3.94	4.88	1.21	5.06	7.96	11.73
Net Cash (Debt)	123.44	30.9	31.52	54.62	27.95	38.54
Net Cash Growth	178.57%	-1.96%	-42.29%	95.42%	-27.48%	-40.37%
Net Cash Per Share	24.48	7.07	9.02	20.83	13.45	25.75
Filing Date Shares Outstanding	7.05	4.56	4.45	3.41	2.4	2.03
Total Common Shares Outstanding	7.05	4.53	3.62	3.39	2.24	1.69
Working Capital	112.43	-6.56	3.69	37.68	18.63	35.62
Book Value Per Share	16.41	-1.81	-3.98	6.36	4.78	22.36
Tangible Book Value	115.63	-8.21	-14.44	21.57	10.72	37.84
Tangible Book Value Per Share	16.41	-1.81	-3.98	6.36	4.78	22.36
Machinery	-	3.32	2.96	3.06	2.97	2.85
Leasehold Improvements	-	0.43	0.43	0.43	0.43	0.43

Source: S&P Capital IQ. Standard template. Financial Sources.